Compugen Announces the Appointment of New Board Members

Compugen Announces the Appointment of New Board Members

HOLON, Israel, June 11, 2018 /PRNewswire/ — Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the appointment of three new members to its Board of Directors. Mr. Gilead Halevy, founding member and general partner of